Parelsnoer Institute Biobank Hereditary Colorectal Cancer: A Joint Infrastructure for Patient Data and Biomaterial on Hereditary Colorectal Cancer in the Netherlands
Each year approximately 15,000 patients are diagnosed with colorectal cancer (CRC) in the Netherlands, of whom 5 –10% are associated with a hereditary syndrome. To enable future research into hereditary CRC, we established a collaborative biobank for hereditary CRC in all eight University Medical Centers (UMCs) in the Netherlands in 2009. This Biobank Hereditary CRC is part of the Parelsnoer Institute (PSI), which is funded by the Dutch Federation of UMCs and the Dutch Government. Besides the multicenter collaboration, the multidisciplinary nature of this biobank – involving Gastroenterology, Genetics and Surgery – ...
Source: Open Journal of Bioresources - April 25, 2019 Category: Biotechnology Source Type: research
The Quebec Respiratory Health Network Biobank
The Quebec Respiratory Health Network (RHN) Biobank is a multi-site infrastructure located in the province of Quebec (Canada) to collect, store, and supply high-quality human biological specimens for research on respiratory diseases. The sample types are diverse (plasma, serum, buffy coat, primary lung cells, lung parenchyma, bronchial biopsies, polyps, others), disease-oriented, and mirror research activities conducted at each site. The biobank currently manages approximately 57,000 specimens from 8,000 research participants or patients treated by standard of care. Specimens’ inventory and corresponding clinical data...
Source: Open Journal of Bioresources - December 31, 2018 Category: Biotechnology Source Type: research
AIDS and Cancer Specimen Resource (ACSR)
The AIDS and Cancer Specimen Resource (ACSR) has four regional biorepositories (RBRs) in the United States and one in South Africa. The ACSR is funded by the National Cancer Institute (NCI) of the National Institutes of Health (United States) to support investigators studying HIV/AIDS and HIV/AIDS-associated malignancies. The ACSR inventory includes more than 450,000 annotated HIV-positive biospecimens from over 10,000 individuals and 100,000 HIV-negative controls from approximately 4,250 individuals, reflecting the pre-highly active antiretroviral therapy (HAART) and post-HAART era of the HIV epidemic, as well as selected...
Source: Open Journal of Bioresources - October 5, 2018 Category: Biotechnology Source Type: research
The Wales Cancer Bank (WCB)
was established in 2004 and consents patients in Wales, UK with a known or suspected cancer diagnosis to donate biosamples for future research. The resource is open access to all researchers working in cancer research, regardless of geographic location or employment sector. To December 2017, just over 13,500 patients have donated samples across a variety of tumour types. Tumour and adjacent normal tissue and blood samples are routinely collected, stored and processed to standardised protocols. Bespoke collections for unique samples such as urine or ascites are also available. Pathology data, clinical data including treatm...
Source: Open Journal of Bioresources - September 18, 2018 Category: Biotechnology Source Type: research
Bioresource of Cervical Tissue Explants from Healthy Women
The York Tissue Bank was established in 2013 at the University of York as a repository for cells and tissues to facilitate clinical and translational research at the university and with collaborative external tissue bank applicants. The bioresource described in this publication was initially established to conduct investigations into infection processes of sexually transmitted diseases inex vivo organotypical models, specifically in uterine cervical tissue. Healthy human uterine cervical tissue is currently available to suitable applicants for ethically approved scientific research meeting the access criteria of the York t...
Source: Open Journal of Bioresources - September 18, 2018 Category: Biotechnology Source Type: research
The Northern Ireland Biobank: A Cancer Focused Repository of Science
The Northern Ireland Biobank (NIB) was established in 2011 as a joint initiative between Queen ’s University Belfast and Belfast Health and Social Care Trust to provide the infrastructure for the standardised collection and storage of high quality, well annotated human tissue samples, with matched bloods and bodily fluids to underpin cancer research in Northern Ireland and beyond. The NIB h as been instrumental in supporting translational research locally, nationally and internationally with a number of key achievements to date. The vision of NIB is to develop an internationally recognised biobank network within Northern...
Source: Open Journal of Bioresources - September 11, 2018 Category: Biotechnology Source Type: research
Dutch Parelsnoer Institute-Cerebrovascular Accident (CVA) Study: A Large Multicenter Clinical Biobank with Standardized Collection and Storage
The Dutch Parelsnoer Institute-Cerebrovascular accident (CVA) Study is part of the Parelsnoer Institute (PSI), initiated in 2007 by the Netherlands Federation of University Medical Centers (NFU). PSI is a cooperation of all eight Dutch University Medical Centers (UMCs) and aims at building large prospectively collected datasets with uniformly and standardized storage of biomaterials for complex diseases. Currently, PSI covers 18 disease-specific cohorts called ‘Pearls’, and this number is still growing. One of these cohorts is the Stroke or CVA Pearl. For each of the cohorts, PSI offers the UMCs an infrastructure and s...
Source: Open Journal of Bioresources - July 19, 2018 Category: Biotechnology Source Type: research
Hospital-integrated Biobanking as a Service – The Interdisciplinary Bank of Biomaterials and Data Wuerzburg (ibdw)
The ibdw was established in 2011 as one of 5 centralised national biobanks in Germany within the framework of the governmental funding program “Nationale Biobank-Initiative”. The ibdw is a joint core facility of both, the University Hospital and the Julius-Maximilians-University Würzburg and acts as a faculty-wide service provider of human biological material for medical research. From the outset main emphasis was placed on comprehen sive automation and seamless integration of sample collection in clinical routine workflows thereby securing highest quality standards. The ibdw collects fluid and tissue samples in para...
Source: Open Journal of Bioresources - April 24, 2018 Category: Biotechnology Source Type: research
Bimetra Biobank: A High Quality Biobank Facility to Stimulate Translational Biomedical Research
Bimetra Biobank is the central high quality biorepository of University Hospital Ghent in collaboration with Ghent University (Belgium). Fully operational since 2015 in a new state-of-the-art biobank facility, Bimetra Biobank acts as a core facility for researchers and third parties looking for high-quality annotated clinical biospecimens. Bimetra Biobank stores about 120.000 clinical samples, both historical collections and prospective collections (disease-based collections, population-based collections and basic research collections) within well-defined and ethically approved research projects. Through a clear governance...
Source: Open Journal of Bioresources - April 24, 2018 Category: Biotechnology Source Type: research
Amniotic Fluid Cells Biobank for Research on Fetal Mesenchymal Stem Cells
The research biobank “Anna Maria Ferraro Cutino” AOR-villa Sofia-Cervello, started in 2010 by a grant of the Sicilian Department of Health. Within the biobank are collected, characterized, stored and distributed amniotic fluids (AF) from amniocentesis performed for maternal age. Patients choose to donate to the biob ank the first 3 ml of AF that cannot be used for prenatal diagnosis. AF and donor data are anonymously archived in a database, according to the standard ethical principles. Collateral biobanks are present to collect, storage and manage donor sera and DNA samples, to perform microbiological and genet ic test...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research
The Radboud Biobank: A Central Facility for Disease-Based Biobanks to Optimise Use and Distribution of Biomaterial for Scientific Research in the Radboud University Medical Center, Nijmegen
The Radboud Biobank offers disease-based biobanks a centralized facility to optimize the use and distribution of biomaterial for scientific research. Notably, two population biobanks are also included in this collection. All collections are professionally and sustainably maintained using high-quality and secure standardized protocols for ICT, legal-ethical aspects, sample collection, processing and storage, communication and distribution. The Radboud Biobank includes biomaterial (e.g. DNA, serum, plasma, tissue, urine and faeces – depending on the specific patient group), images, associated clinical data (patient, diseas...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research
The Tumour Bank at the Children ’s Hospital at Westmead: An Australian Paediatric Cancer Biorepository
In conclusion, the Children’s Hospital at Westmead Tumour Bank has demonstrated a sustained single institutional biorepository model for facilitating translational research of rare cancer. It has provided strong evidence that integration of a single institutional biobank into standard clinical practices would be the long-term pathway of valuable bio-resource for rare cancer research. Published on 2018-02-06 13:29:59 (Source: Open Journal of Bioresources)
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research
Tumorbank@uza: A Collection of Tissue, Fluid Samples and Associated Data of Oncology Patients for the Use in Translational Research
Tumorbank@UZA is an academic hospital integrated biobank that collects tissue, blood and urine samples from oncology patients. We work according to a quality management system and have established SOPs for all work procedures in the biobank. Tumorbank@UZA is funded by the National Cancer Plan, an initiative from the Belgian government since 2009. Samples from our biobank are available for both academic as well as commercial researchers, through a well-established access procedure. Currently the collection consists of more than 85.000 samples of more than 8000 patients. Funding statement:Tumorbank@UZA is funded by the Nati...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research
The Brisbane Breast Bank
(BBB) was established in 2005 with a view to collecting surplus tissue from every breast surgery patient at the Royal Brisbane and Women ’s Hospital. This not-for-profit biobank provides resources on a collaborative basis, supporting local, national and international studies. The resource prides itself on its comprehensive clinico-pathology sample annotation. Since its inception, the remit of the BBB has expanded to the prospective collection of serial blood samples from patients at high risk of recurrence, and the collection of blood and tumour tissue from metastatic patients. Funding statement:RBWH Foundation Diamond...
Source: Open Journal of Bioresources - February 6, 2018 Category: Biotechnology Source Type: research
Biobank Graz: The Hub for Innovative Biomedical Research
Biobank Graz was established in 2007 as publicly funded, non-profit central research facility of Medical University of Graz, Austria. Biobank Graz is ISO 9001:2008 certified and stores about 7.5 million samples and their associated data, including formalin fixed paraffin embedded (FFPE) and fresh frozen tissues plus fluid samples (serum, plasma, full blood, urine and cerebrospinal, follicular and seminal fluids, etc.) covering 30 years of collection. Samples are handled and stored in semi or fully automated systems to optimally maintain sample quality and retrieval rates. With its broad informed consent, Biobank Graz distr...
Source: Open Journal of Bioresources - July 6, 2017 Category: Biotechnology Source Type: research
